CRIS Current Research Information System

Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, et al. (2009). ERCC 1/BRCA1 protein expressions and ERCC1/XPD/XRCC1-3 gene polymorphisms as predictor factors of outcome in stage III-IV non-small cell lung cancer (NSCLC) patients treated in first-line chemotherapy with or without cisplatin. JOURNAL OF THORACIC ONCOLOGY, 4(9), S402-S402.

ERCC 1/BRCA1 protein expressions and ERCC1/XPD/XRCC1-3 gene polymorphisms as predictor factors of outcome in stage III-IV non-small cell lung cancer (NSCLC) patients treated in first-line chemotherapy with or without cisplatin

ARDIZZONI, ANDREA
2009
2009
Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, et al. (2009). ERCC 1/BRCA1 protein expressions and ERCC1/XPD/XRCC1-3 gene polymorphisms as predictor factors of outcome in stage III-IV non-small cell lung cancer (NSCLC) patients treated in first-line chemotherapy with or without cisplatin. JOURNAL OF THORACIC ONCOLOGY, 4(9), S402-S402.
Tiseo M; Bordi P; Bortesi B; Boni L; Boni C; Baldini E; Grossi F; Recchia F; Zanelli F; Fontanini G; Naldi N; Bordi C; Ardizzoni A
1.06 Abstract in rivista
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/595284
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact